These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37892450)

  • 21. Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism.
    Li SZ; Zhang NN; Yang X; Huang TQ; Lin Y; Jiang ZM; Yi Y; Liu EH
    J Agric Food Chem; 2023 May; 71(19):7312-7323. PubMed ID: 37139957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
    Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease.
    Zhang D; Wang H; Liu A; Wang S; Xu C; Lan K; Xiang W; Zhu K; Xiao Y; Fu J; Jiang R; Chen W; Ni Y
    J Nutr Biochem; 2023 Nov; 121():109434. PubMed ID: 37661068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
    Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
    Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism.
    Huang X; Chen Q; Fan Y; Yang R; Gong G; Yan C; Song Y; Zhang B; Xi S; Huang Y; Xu H
    Biomed Pharmacother; 2023 Mar; 159():114300. PubMed ID: 36696803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
    Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
    Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis.
    Zheng Y; Ying H; Shi J; Li L; Zhao Y
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
    Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
    Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut-Liver Axis.
    Xu Y; Huang X; Huangfu B; Hu Y; Xu J; Gao R; Huang K; He X
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota.
    Xu J; Tian H; Ji Y; Dong L; Liu Y; Wang Y; Gao X; Shi H; Li H; Yang L
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2687-2699. PubMed ID: 37126194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Strains of
    Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallotannin Isolated from Pericarp of Water Caltrop Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    Lü H; Meng X; Ding X; Jian T; Zuo Y; Liu Y; Ren B; Li W; Chen J
    J Agric Food Chem; 2023 May; 71(18):7046-7057. PubMed ID: 37113100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress.
    Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X
    Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
    Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
    Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
    J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-protein compound yogurt with quinoa improved clinical features and metabolism of high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Shi L; Tianqi F; Zhang C; Deng X; Zhou Y; Wang J; Wang L
    J Dairy Sci; 2023 Aug; 106(8):5309-5327. PubMed ID: 37474360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
    Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
    Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
    Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway.
    Ding J; Wu L; Zhu G; Zhu J; Luo P; Li Y
    Mol Biol Rep; 2023 Feb; 50(2):961-970. PubMed ID: 36376538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.